NCAAIS 2017 Annual Meeting

Concord, NC US
April 28, 2017 to April 29, 2017

Didactic lectures discussing contact dermatitis, patch testing basics and common allergens in depth. Hands on workshop to allow physicians to become familiar with patch testing.

NCAAIS 2017 Annual Meeting
April 28 – 29, 2017
Great Wolf Lodge | Concord, NC
Friday, April 28, 2017
6:00 – 7:00 pm        FIT Posters
7:00 – 8:00 pm        Product Theater – Not for credit        

Saturday, April 29, 2017
6.45 – 7:00 am        Breakfast buffet
7:00 – 8:00 am        Non-Infectious Manifestations of Primary Immunodeficiency Syndromes
                                Jennifer Leiding, MD
8:00 – 9:00 am        Biologic Therapies for the Treatment of Severe Asthma
                                Kevin Murphy, MD
9:00 – 10:00 am      Updates on the Practical Approach to Evaluating the Patient with Suspected Primary Immunodeficiency Disease (PIDD)
                                John Sleasman, MD
10:00 – 10:15 am    Refreshment break
10:15 – 11:15 am    Patient & Community Advocacy & Education: Making a Difference in Your Community
                                Tonya Winders                    
11:30 – 12:30 am    Business Meeting Luncheon - News from SC Allergy Meeting
12:30 – 3:00 pm      Contact Dermatitis Update and Workshop
                                Luz Fonacier, MD
3:00 – 3:15 pm        Refreshment break
3:15 – 4:15 pm        Building a Clinical Research Center
                                Cheryl Bernstein, RN                    
4:15 – 5:15 pm        Practice Profitability
                                Kay Tyler, RN
5:15 pm                   Meeting Adjourned

This activity is jointly provided by the American College of Allergy, Asthma & Immunology and North Carolina Allergy, Asthma & Immunology Society.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American College of Allergy, Asthma & Immunology (ACAAI) and the North Carolina Allergy, Asthma & Immunology Society (NCAAIS).  The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American College of Allergy, Asthma & Immunology (ACAAI) designates this live activity for a maximum of 8.50 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

In compliance with the Americans with Disabilities Act, NCAAIS requests that any participant in need of accommodation contact Sonia Bains, MD at

Target Audience

Practicing allergists

Learning Objectives

Upon completion of this activity, participants should be able to:
Discuss the immunological pathways and diagnostic workup of immunodeficiency disorders  
Discuss how to incorporate clinical research in private practice  
Review existing and new biologics in the pipeline for asthma 
Discuss appropriate patient selection for various biologics 
Discuss risks and benefits
Discuss coding for the practicing allergist 
Discuss the diagnosis and management of contact dermatitis  
Discuss patch testing: utility, performance, interpretation, and coding  
Participate in a hands-on workshop on how to perform patch testing and how to incorporate it into clinical practice

Additional information

Disclosure Policy and Disclosures
As required by the Accreditation Council for Continuing Medical Education (ACCME) and in accordance with the American College of Allergy, Asthma and Immunology (ACAAI) policy, all educational planners, presenters, instructors, moderators, authors, reviewers, and other individuals in a position to control or influence the content of an activity must disclose all relevant financial relationships with any commercial interest that have occurred within the past 12 months. All identified conflicts of interest must be resolved and the educational content thoroughly vetted for fair balance, scientific objectivity, and appropriateness of patient care recommendations. It is required that disclosure be provided to the learners prior to the start of the activity. Individuals with no relevant financial relationships must also inform the learners that no relevant financial relationships exist. Learners must also be informed when off-label, experimental/investigational uses of drugs or devices are discussed in an educational activity or included in related materials. Disclosure in no way implies that the information presented is biased or of lesser quality. It is incumbent upon course participants to be aware of these factors in interpreting the program contents and evaluating recommendations. Moreover, expressed views do not necessarily reflect the opinions of the ACAAI. 

All identified conflicts of interest have been resolved.

Maeve O’Connor – CME Planner
Mylan - Advisory Board/Speaker
Meda – Advisory Board/Speaker
Teva - Advisory Board/Speaker
Kaleo - Advisory Board/Speaker
Merck - Advisory Board/Speaker
Greer - Advisory Board/Speaker
Circassia - Advisory Board/Speaker
Spirometrix - Advisory Board

Jennifer Caicedo, MD – CME Planner
Nutricia – Speaker
Mylan – Consultant

Kevin Murphy, MD – Speaker 
Astra Zeneca – Consultant/Advisory Board/Speaker/
Boehringer-Ingelheim – Consultant/Advisory Board/Speaker
Genentech – Consultant/Advisory Board/Speaker
Greer- Consultant/Advisory Board/Speaker
Merck – Consultant/Advisory Board/Speaker
Meda – Consultant/Advisory Board/Speaker
Mylan- Consultant/Advisory Board/Speaker
Novartis – Consultant/Advisory Board/Speaker
Teva – Consultant/Advisory Board/Speaker/Research Grant

Jennifer Leiding, MD - Speaker
Horizon Pharma - Consultant/Advisory Board/Speaker

Luz Fonacier, MD
Genentech - Research and Educational Grants (to Winthrop University Hospital)
Baxter - Research and Educational Grants (to Winthrop University Hospital)
Regeneron – Consultant
Church & Dwight – Consultant

Cheryl Bernstein, RN – Speaker
Dyax – contracted research
Shire – contracted research
Merck- contracted research
GSK - contracted research
Boehringer-Ingelheim - contracted research
Quintiles - contracted research
AstraZeneca - contracted research
Meda - contracted research
Pearl - contracted research
Teva - contracted research
Inflamax - contracted research
Stallergenes - contracted research
Novartis - contracted research
Genentech - contracted research
Circassia - contracted research
Regeneron - contracted research

The following have no relevant financial relationships to disclose:

John Sleasman, MD – Speaker
Tonya Winders, MBA – Speaker
Kay Tyler, RN - Speaker
David Fitzhugh, MD- CME Planner
Sonia Bains, MD – Treasurer NCAAIS (CME Planner/Reviewer)

Course summary
Available credit: 
  • 8.50 AMA PRA Category 1 Credit™
  • 8.50 Attendance
Course opens: 
Course expires: 
Event starts: 
04/28/2017 - 7:00pm
Event ends: 
04/29/2017 - 5:15pm
Great Wolf Lodge
10175 Weddington Road
Concord, NC 28027
United States

Available Credit

  • 8.50 AMA PRA Category 1 Credit™
  • 8.50 Attendance

Accreditation Period

Course opens: 
Course expires: 


Please login or create an account to take this course.